Position in MREO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$16,567
+$595 QoQ
Shares Held
52,100
+7.6% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 58 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MREO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. MREO ranks #303 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in MREO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,567 | 52,100 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $15,972 | 48,400 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $81,052 | 194,371 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,217,194 | 590,871 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,012,076 | 1,480,471 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,038,559 | 1,350,471 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,163,148 | 1,189,471 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,365,074 | 1,305,371 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,343,210 | 1,762,003 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,518,619 | 1,672,309 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,153,400 | 1,798,009 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,228,565 | 1,727,570 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,347,979 | 1,778,772 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $647,547 | 915,909 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $943,026 | 1,257,369 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,062,141 | 1,233,614 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $681,978 | 608,909 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $317,856 | 283,800 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $352,960 | 220,600 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $965,338 | 398,900 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $903,767 | 285,100 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $900,464 | 267,200 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,285,936 | 359,200 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $55,544 | 21,200 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $154,224 | 50,400 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||